Results 211 to 220 of about 4,881,376 (355)

Renal hemodynamics and renal kinins after angiotensin-converting enzyme inhibition

open access: bronze, 1981
Barbara H. Clappison   +2 more
openalex   +1 more source

Angiotensin-converting-enzyme inhibition in stable coronary artery disease.

open access: yesNew England Journal of Medicine, 2004
E. Braunwald   +9 more
semanticscholar   +1 more source

Identification of functional murine mitochondrial formyl peptides and their effects on myeloid‐derived suppressor cell generation

open access: yesFEBS Open Bio, EarlyView.
We first identified functional murine mitochondrial N‐formyl peptides (MT‐FPs) and investigated their effects on the in vitro myeloid‐derived suppressor cell (MDSC) generation from bone marrow cells. We demonstrated that MT‐FPs acted directly on bone marrow cells to promote MDSC generation and modulated the polymorphonuclear (PMN)‐MDSC/monocyte (M ...
Miyako Ozawa   +2 more
wiley   +1 more source

Nitric oxide synthases: structure, function and inhibition.

open access: yesBiochemical Journal, 2001
W. Alderton   +2 more
semanticscholar   +1 more source

Establishing an assay to evaluate d‐amino acid oxidase enzyme kinetics and inhibition using WST‐8 redox dye

open access: yesFEBS Open Bio, EarlyView.
This study investigated a novel WST‐8‐based assay for evaluating d‐Amino acid oxidase (DAO) inhibitors. We confirmed its effectiveness using known inhibitors and found that uremic toxins possess relatively weak inhibitory activity compared to existing drugs.
Kahoko Miyake   +4 more
wiley   +1 more source

Phenolic profile of different solvent extracts of <i>Reseda alba</i> L. and evaluation of anti-quorum sensing, antioxidant, and enzyme inhibition activities. [PDF]

open access: yesFront Nutr
Nacer M   +11 more
europepmc   +1 more source

Matrix metalloproteinase‐9 regulates cell adhesion and membrane protrusive activity of ovarian cancer cells

open access: yesFEBS Open Bio, EarlyView.
Matrix metalloproteinase‐9 (MMP9) drives ovarian cancer progression. Using MMP9‐null cells (M9‐KO) created from ovarian cancer cells, we found MMP9 loss did not block Epidermal Growth Factor (EGF)‐driven E‐cadherin dissolution or EMT but delayed and reduced EGF‐driven membrane protrusions. Transient MMP9 re‐expression drove membrane protrusion.
Claire Strauel   +8 more
wiley   +1 more source

New treatment for pyridoxine-dependent epilepsy due to ALDH7A1 deficiency: first proof-of-principle of upstream enzyme inhibition in the mouse. [PDF]

open access: yesBrain Commun
van Karnebeek CDM   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy